BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 25215506)

  • 1. Discovery and validation of new potential biomarkers for early detection of colon cancer.
    Solé X; Crous-Bou M; Cordero D; Olivares D; Guinó E; Sanz-Pamplona R; Rodriguez-Moranta F; Sanjuan X; de Oca J; Salazar R; Moreno V
    PLoS One; 2014; 9(9):e106748. PubMed ID: 25215506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein and glycomic plasma markers for early detection of adenoma and colon cancer.
    Rho JH; Ladd JJ; Li CI; Potter JD; Zhang Y; Shelley D; Shibata D; Coppola D; Yamada H; Toyoda H; Tada T; Kumada T; Brenner DE; Hanash SM; Lampe PD
    Gut; 2018 Mar; 67(3):473-484. PubMed ID: 27821646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteomic Profiling of Serial Prediagnostic Serum Samples for Early Detection of Colon Cancer in the U.S. Military.
    Shao S; Neely BA; Kao TC; Eckhaus J; Bourgeois J; Brooks J; Jones EE; Drake RR; Zhu K
    Cancer Epidemiol Biomarkers Prev; 2017 May; 26(5):711-718. PubMed ID: 28003179
    [No Abstract]   [Full Text] [Related]  

  • 4. A novel multiplex-protein array for serum diagnostics of colon cancer: a case-control study.
    Bünger S; Haug U; Kelly M; Posorski N; Klempt-Giessing K; Cartwright A; Fitzgerald SP; Toner V; McAleer D; Gemoll T; Laubert T; Büning J; Fellermann K; Bruch HP; Roblick UJ; Brenner H; von Eggeling F; Habermann JK
    BMC Cancer; 2012 Sep; 12():393. PubMed ID: 22954206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel screening test for colon cancer: Talin-1.
    Bostanci O; Kemik O; Kemik A; Battal M; Demir U; Purisa S; Mihmanli M
    Eur Rev Med Pharmacol Sci; 2014; 18(17):2533-7. PubMed ID: 25268101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a panel of serum IgG and IgA autoantibodies for early diagnosis of colon cancer.
    Chen M; Lin X; Zhang L; Yu L; Wu Q; Zhang S; Xue F; Huang Y
    Int J Med Sci; 2020; 17(17):2744-2750. PubMed ID: 33162802
    [No Abstract]   [Full Text] [Related]  

  • 7. The clinical significance of DC-SIGN and DC-SIGNR, which are novel markers expressed in human colon cancer.
    Jiang Y; Zhang C; Chen K; Chen Z; Sun Z; Zhang Z; Ding D; Ren S; Zuo Y
    PLoS One; 2014; 9(12):e114748. PubMed ID: 25504222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proximal fluid proteome profiling of mouse colon tumors reveals biomarkers for early diagnosis of human colorectal cancer.
    Fijneman RJ; de Wit M; Pourghiasian M; Piersma SR; Pham TV; Warmoes MO; Lavaei M; Piso C; Smit F; Delis-van Diemen PM; van Turenhout ST; Terhaar sive Droste JS; Mulder CJ; Blankenstein MA; Robanus-Maandag EC; Smits R; Fodde R; van Hinsbergh VW; Meijer GA; Jimenez CR
    Clin Cancer Res; 2012 May; 18(9):2613-24. PubMed ID: 22351690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic and prognostic utility of serum receptor-binding cancer antigen expressed on SiSo cells (RCAS1) levels in colon cancer patients.
    Giaginis C; Margeli A; Kouraklis G; Zira A; Tsourouflis G; Theocharis S
    Int J Biol Markers; 2009; 24(2):70-6. PubMed ID: 19634109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MAPRE1 as a plasma biomarker for early-stage colorectal cancer and adenomas.
    Taguchi A; Rho JH; Yan Q; Zhang Y; Zhao Y; Xu H; Tripathi SC; Wang H; Brenner DE; Kucherlapati M; Kucherlapati R; Boutin AT; Wang YA; DePinho RA; Feng Z; Lampe PD; Hanash SM
    Cancer Prev Res (Phila); 2015 Nov; 8(11):1112-9. PubMed ID: 26342024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased serum levels of complement C3a anaphylatoxin indicate the presence of colorectal tumors.
    Habermann JK; Roblick UJ; Luke BT; Prieto DA; Finlay WJ; Podust VN; Roman JM; Oevermann E; Schiedeck T; Homann N; Duchrow M; Conrads TP; Veenstra TD; Burt SK; Bruch HP; Auer G; Ried T
    Gastroenterology; 2006 Oct; 131(4):1020-9; quiz 1284. PubMed ID: 17030172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of kininogen-1 as a serum biomarker for the early detection of advanced colorectal adenoma and colorectal cancer.
    Wang J; Wang X; Lin S; Chen C; Wang C; Ma Q; Jiang B
    PLoS One; 2013; 8(7):e70519. PubMed ID: 23894665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Initial analyses of colon cancer-specific antigen (CCSA)-3 and CCSA-4 as colorectal cancer-associated serum markers.
    Leman ES; Schoen RE; Weissfeld JL; Cannon GW; Sokoll LJ; Chan DW; Getzenberg RH
    Cancer Res; 2007 Jun; 67(12):5600-5. PubMed ID: 17575123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of serum proteomics to detect large colon adenomas.
    Ransohoff DF; Martin C; Wiggins WS; Hitt BA; Keku TO; Galanko JA; Sandler RS
    Cancer Epidemiol Biomarkers Prev; 2008 Aug; 17(8):2188-93. PubMed ID: 18708413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early detection of colon cancer by amino acid profiling using AminoIndex Technology: a case report.
    Yatabe J; Yatabe MS; Ishibashi K; Nozawa Y; Sanada H
    Diagn Pathol; 2013 Dec; 8():203. PubMed ID: 24325735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oncostatin-M as a novel biomarker in colon cancer patients and its association with clinicopathologic variables.
    Gurluler E; Tumay LV; Guner OS; Kucukmetin NT; Hizli B; Zorluoglu A
    Eur Rev Med Pharmacol Sci; 2014; 18(14):2042-7. PubMed ID: 25027345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of EFEMP2 as a serum biomarker for the early detection of colorectal cancer with lectin affinity capture assisted secretome analysis of cultured fresh tissues.
    Yao L; Lao W; Zhang Y; Tang X; Hu X; He C; Hu X; Xu LX
    J Proteome Res; 2012 Jun; 11(6):3281-94. PubMed ID: 22506683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of tumour-associated antigen (TAA) miniarray in immunodiagnosis of colon cancer.
    Liu W; Wang P; Li Z; Xu W; Dai L; Wang K; Zhang J
    Scand J Immunol; 2009 Jan; 69(1):57-63. PubMed ID: 19140877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gel-Based Proteomics of Clinical Samples Identifies Potential Serological Biomarkers for Early Detection of Colorectal Cancer.
    Thorsen SF; Gromova I; Christensen IJ; Fredriksson S; Andersen CL; Nielsen HJ; Stenvang J; Moreira JMA
    Int J Mol Sci; 2019 Dec; 20(23):. PubMed ID: 31810358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clusterin in stool: a new biomarker for colon cancer screening?
    Pucci S; Bonanno E; Sesti F; Mazzarelli P; Mauriello A; Ricci F; Zoccai GB; Rulli F; Galatà G; Spagnoli LG
    Am J Gastroenterol; 2009 Nov; 104(11):2807-15. PubMed ID: 19623170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.